NEW YORK (GenomeWeb) – Champions Oncology announced today that it has been awarded a two-year, $2 million Small Business Innovation Research grant from the National Cancer Institute to support a project to develop and evaluate the utility of an ethnically diverse group of metastatic prostate cancer patient-derived xenograft (PDX) models.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.